Skip to main content
Clinical Trials/NCT00168623
NCT00168623
Unknown
Phase 4

Randomised Trial of Vitamin A Supplementation Given With Routine Childhood Vaccines at National Immunisation Days

Bandim Health Project1 site in 1 country6,200 target enrollmentNovember 2003

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Mortality
Sponsor
Bandim Health Project
Enrollment
6200
Locations
1
Primary Endpoint
Mortality
Last Updated
12 years ago

Overview

Brief Summary

Vitamin A supplementation (VAS) is important for the immune system and may interact with different childhood vaccinations. We have hypothesized that the improved survival after VAS may depend on vitamin A amplifying the non-specific immune modulation induced by vaccinations.

In the present study we used information collected in connection with a national vitamin A campaign in Guinea-Bissau during which different doses of VAS was provided together with missing doses of DTP, OPV, and measles vaccines. We aimed to study the potential interactions between VAS and vaccine type.

Detailed Description

Vitamin A supplementation (VAS) acts as an adjuvant to vaccines, and VAS has been shown to enhance both cellular and humoral immune responses in animals and in humans. Routine childhood vaccinations have recently been shown to have important non-targeted effects on mortality, i.e. effects that cannot be explained merely by the prevention of the targeted disease. We have hypothesized that the improved survival after VAS may depend not only on the prevention of vitamin A deficiency, but also on vitamin A amplifying the non-specific immune modulation induced by routine vaccinations. In the present study we used information collected in connection with a national vitamin A campaign in Guinea-Bissau during which different doses of VAS was provided together with missing doses of DTP, OPV, and measles vaccines. We aimed to study the potential interactions between VAS and vaccine type.

Registry
clinicaltrials.gov
Start Date
November 2003
End Date
December 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Between 6 months and 5 years and thus eligible for vitamin A and missing vaccines during national immunisation days -

Exclusion Criteria

  • Overt signs of vitamin A deficiency

Outcomes

Primary Outcomes

Mortality

Morbidity

Both outcomes analysed according to vaccine received and sex

Study Sites (1)

Loading locations...

Similar Trials